-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Introduction
Alfacalcidol is a synthetic form of vitamin D, which is essential for the proper functioning of the human body.
It is used to treat conditions such as rickets, osteomalacia, and hypocalcemia.
This article will explore the synthetic routes of alfacalcidol, which are widely used in the chemical industry to produce this important compound.
Synthetic routes for alfacalcidol
There are several synthetic routes for alfacalcidol, each with its own advantages and limitations.
The following are the most commonly used synthetic routes for alfacalcidol:
- Synthesis via the Davis-Mayo route: This is the most widely used synthetic route for alfacalcidol.
It involves the reaction of ergosterol with tetrabutylammonium hydroxide to form pre-vitamin D3, which is then converted to vitamin D2 in the presence of UV light.
The resulting vitamin D2 is then converted to alfacalcidol using hydrochloric acid.
This route is relatively simple and economical, but it requires the use of hazardous reagents such as tetrabutylammonium hydroxide. - Synthesis via the Beyer-Wiener route: This route involves the reaction of cholesterol with formaldehyde and sodium hydroxide to form pre-vitamin D3, which is then converted to vitamin D2 using UV light.
The vitamin D2 is then reduced to alfacalcidol using hydrogen gas in the presence of a reducing agent such as lithium aluminum hydride.
This route is more complex than the Davis-Mayo route, but it does not require the use of hazardous reagents. - Synthesis via the Kearns-Hayes route: This route involves the reaction of ergosterol with sodium hydroxide to form pre-vitamin D3, which is then converted to alfacalcidol using hydrochloric acid and hydrogenation.
This route is similar to the Davis-Mayo route, but it requires the use of hydrogenation to reduce the resulting vitamin D2 to alfacalcidol.
Advantages and limitations of the synthetic routes
Each of the synthetic routes for alfacalcidol has its own advantages and limitations.
The Davis-Mayo route is relatively simple and economical, but it requires the use of hazardous reagents.
The Beyer-Wiener route does not require the use of hazardous reagents, but it is more complex and requires more steps.
The Kearns-Hayes route is similar to the Davis-Mayo route, but it requires the use of hydrogenation to reduce the resulting vitamin D2 to alfacalcidol.
Another important consideration when selecting a synthetic route for alfacalcidol is the purity of the resulting product.
The Davis-Mayo and Kearns-Hayes routes typically produce a higher-purity alfacalcidol compared to the Beyer-Wiener route, which can have impurities that need to be removed.
Conclusion
Alfacalcidol is an important synthetic compound used in the treatment of various conditions related to vitamin D deficiency.
There are several synthetic routes for alfacalcidol, each with its own advantages and limitations.
The most commonly used synthetic route is the Davis-Mayo route, which is relatively simple and economical.
However, the use of hazardous reagents such as tetrabutylammonium hydroxide needs to be considered when selecting this route.
The selection of a synthetic route for alfacalcidol must also consider the purity of the resulting product.